CN Stock MarketDetailed Quotes

688513 Chengdu Easton Biopharmaceuticals

Watchlist
  • 56.02
  • +1.19+2.17%
Market Closed May 31 15:00 CST
6.73BMarket Cap27.97P/E (TTM)

Chengdu Easton Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
13.37%314.99M
-4.56%1.12B
-5.33%849.78M
-3.48%555.36M
3.31%277.85M
14.43%1.17B
16.05%897.59M
15.38%575.41M
21.56%268.95M
10.96%1.02B
Operating revenue
13.37%314.99M
-4.56%1.12B
-5.33%849.78M
-3.48%555.36M
3.31%277.85M
14.43%1.17B
16.05%897.59M
15.38%575.41M
21.56%268.95M
10.96%1.02B
Total operating cost
14.04%258.24M
-4.73%951.86M
-6.88%691.11M
-3.24%447.75M
0.31%226.45M
13.04%999.14M
13.72%742.16M
12.68%462.76M
20.91%225.75M
11.04%883.9M
Operating cost
26.28%63.55M
13.91%223.27M
13.79%159.92M
10.36%99.68M
10.14%50.33M
36.77%196M
41.81%140.54M
51.21%90.32M
79.59%45.7M
36.51%143.31M
Operating tax surcharges
12.29%4.93M
-1.78%17.83M
6.89%13.44M
7.17%8.71M
11.67%4.39M
15.25%18.15M
3.46%12.57M
-0.96%8.13M
15.65%3.93M
11.91%15.75M
Operating expense
12.63%115.64M
-18.89%384.56M
-21.51%287.13M
-18.23%190.52M
-12.27%102.67M
1.29%474.14M
3.85%365.83M
4.94%232.99M
13.03%117.04M
-0.84%468.1M
Administration expense
-9.75%20.87M
9.49%98.87M
11.23%71.91M
30.23%47.76M
41.13%23.12M
50.61%90.3M
45.24%64.65M
27.19%36.67M
17.00%16.39M
10.82%59.96M
Financial expense
77.27%-944.57K
-8.94%-11.16M
-54.61%-10.06M
-20.27%-5.66M
-66.33%-4.16M
-161.32%-10.24M
-101.06%-6.51M
-95.52%-4.71M
-67.96%-2.5M
-25.62%-3.92M
-Interest expense (Financial expense)
34.69%976.43K
31.15%3.42M
82.32%2.49M
158.78%1.57M
294.54%724.96K
615.65%2.61M
345.54%1.37M
98.60%607.79K
-28.52%183.75K
-49.73%364.15K
-Interest Income (Financial expense)
58.10%-2.06M
-14.44%-14.7M
-57.75%-12.68M
-34.06%-7.2M
-79.94%-4.92M
-187.08%-12.84M
-116.11%-8.04M
-89.83%-5.37M
-51.04%-2.74M
-19.86%-4.47M
Research and development
8.18%54.18M
3.34%238.49M
2.23%168.77M
7.43%106.74M
10.83%50.09M
14.99%230.79M
11.67%165.08M
5.37%99.35M
8.13%45.19M
30.40%200.7M
Credit Impairment Loss
-6,106.33%-2.31M
125.57%384.48K
47.52%-796.4K
135.39%1.4M
-104.00%-37.25K
-166.06%-1.5M
-1,243.85%-1.52M
2,354.80%593.98K
-22.41%931.97K
206.82%2.28M
Asset Impairment Loss
32.52%-178.86K
-13.41%-2.63M
58.65%-886.68K
55.06%-440.52K
55.58%-265.05K
-21.96%-2.32M
-116.27%-2.14M
-245.39%-980.27K
-412.35%-596.74K
3.49%-1.9M
Other net revenue
Fair value change income
-23.25%3.16M
-27.13%14.57M
-34.71%13.5M
-44.65%7.98M
-32.45%4.12M
46.03%19.99M
61.21%20.67M
62.87%14.41M
--6.09M
--13.69M
Invest income
45.80%3.13M
38.95%10.91M
48.66%5.55M
81.72%5.07M
28.43%2.15M
-72.31%7.85M
-74.17%3.73M
-78.12%2.79M
-53.88%1.67M
197.51%28.35M
-Including: Investment income associates
-88.29%11.56K
-72.51%144.33K
--151.77K
--132.52K
--98.75K
--524.98K
----
----
----
----
Asset deal income
---2.29K
-48.20%133.29K
--13.74K
--13.74K
----
--257.29K
----
----
----
----
Other revenue
80.25%19.67M
-18.25%53.11M
1.79%35.39M
36.97%23.08M
81.06%10.91M
3.63%64.97M
-41.28%34.77M
0.78%16.85M
-17.79%6.03M
-7.04%62.69M
Operating profit
17.49%80.22M
-7.25%241.74M
0.23%211.44M
-1.10%144.7M
19.08%68.28M
6.75%260.63M
2.30%210.95M
16.10%146.31M
22.27%57.34M
22.82%244.15M
Add:Non operating Income
-89.17%269.18
-93.18%104.22K
-80.19%102.14K
-18.28%12.56K
-72.49%2.49K
-81.45%1.53M
521.55%515.46K
-81.39%15.37K
3,827.93%9.03K
1,540.50%8.23M
Less:Non operating expense
218.70%129.97K
20.81%201.55K
-46.62%81.68K
-66.49%51.26K
4.85%40.78K
-96.95%166.83K
-97.11%153K
102.07%152.95K
56.90%38.89K
2,119.23%5.46M
Total profit
17.37%80.09M
-7.77%241.64M
0.07%211.46M
-1.03%144.66M
19.07%68.24M
6.10%261.99M
5.13%211.31M
15.98%146.17M
22.27%57.31M
24.05%246.92M
Less:Income tax cost
-29.95%5.08M
-2.60%15.07M
12.20%17.75M
13.89%13.14M
106.87%7.25M
6.73%15.47M
5.95%15.82M
32.80%11.54M
-1.98%3.51M
-30.62%14.49M
Add:Adjusted items effecting net profit
----
----
----
----
----
----
----
---0.01
----
----
Net profit
23.00%75.01M
-8.09%226.57M
-0.91%193.72M
-2.31%131.52M
13.35%60.99M
6.06%246.52M
5.06%195.49M
14.74%134.64M
24.28%53.8M
30.46%232.43M
Net profit from continuing operation
23.00%75.01M
-8.09%226.57M
-0.91%193.72M
-2.31%131.52M
13.35%60.99M
6.06%246.52M
5.06%195.49M
14.74%134.64M
24.28%53.8M
30.46%232.43M
Net profit of parent company owners
23.00%75.01M
-8.09%226.57M
-0.91%193.72M
-2.31%131.52M
13.35%60.99M
6.06%246.52M
5.06%195.49M
14.74%134.64M
24.28%53.8M
30.46%232.43M
Earning per share
Basic earning per share
23.53%0.63
-7.80%1.89
-1.23%1.61
-1.79%1.1
13.33%0.51
5.67%2.05
5.16%1.63
14.29%1.12
25.00%0.45
8.99%1.94
Diluted earning per share
23.53%0.63
-7.80%1.89
-1.23%1.61
-1.79%1.1
13.33%0.51
5.67%2.05
5.16%1.63
14.29%1.12
25.00%0.45
8.99%1.94
Other composite income
Total composite income
23.00%75.01M
-8.09%226.57M
-0.91%193.72M
-2.31%131.52M
13.35%60.99M
6.06%246.52M
5.06%195.49M
14.74%134.64M
24.28%53.8M
30.46%232.43M
Total composite income of parent company owners
23.00%75.01M
-8.09%226.57M
-0.91%193.72M
-2.31%131.52M
13.35%60.99M
6.06%246.52M
5.06%195.49M
14.74%134.64M
24.28%53.8M
30.46%232.43M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 13.37%314.99M-4.56%1.12B-5.33%849.78M-3.48%555.36M3.31%277.85M14.43%1.17B16.05%897.59M15.38%575.41M21.56%268.95M10.96%1.02B
Operating revenue 13.37%314.99M-4.56%1.12B-5.33%849.78M-3.48%555.36M3.31%277.85M14.43%1.17B16.05%897.59M15.38%575.41M21.56%268.95M10.96%1.02B
Total operating cost 14.04%258.24M-4.73%951.86M-6.88%691.11M-3.24%447.75M0.31%226.45M13.04%999.14M13.72%742.16M12.68%462.76M20.91%225.75M11.04%883.9M
Operating cost 26.28%63.55M13.91%223.27M13.79%159.92M10.36%99.68M10.14%50.33M36.77%196M41.81%140.54M51.21%90.32M79.59%45.7M36.51%143.31M
Operating tax surcharges 12.29%4.93M-1.78%17.83M6.89%13.44M7.17%8.71M11.67%4.39M15.25%18.15M3.46%12.57M-0.96%8.13M15.65%3.93M11.91%15.75M
Operating expense 12.63%115.64M-18.89%384.56M-21.51%287.13M-18.23%190.52M-12.27%102.67M1.29%474.14M3.85%365.83M4.94%232.99M13.03%117.04M-0.84%468.1M
Administration expense -9.75%20.87M9.49%98.87M11.23%71.91M30.23%47.76M41.13%23.12M50.61%90.3M45.24%64.65M27.19%36.67M17.00%16.39M10.82%59.96M
Financial expense 77.27%-944.57K-8.94%-11.16M-54.61%-10.06M-20.27%-5.66M-66.33%-4.16M-161.32%-10.24M-101.06%-6.51M-95.52%-4.71M-67.96%-2.5M-25.62%-3.92M
-Interest expense (Financial expense) 34.69%976.43K31.15%3.42M82.32%2.49M158.78%1.57M294.54%724.96K615.65%2.61M345.54%1.37M98.60%607.79K-28.52%183.75K-49.73%364.15K
-Interest Income (Financial expense) 58.10%-2.06M-14.44%-14.7M-57.75%-12.68M-34.06%-7.2M-79.94%-4.92M-187.08%-12.84M-116.11%-8.04M-89.83%-5.37M-51.04%-2.74M-19.86%-4.47M
Research and development 8.18%54.18M3.34%238.49M2.23%168.77M7.43%106.74M10.83%50.09M14.99%230.79M11.67%165.08M5.37%99.35M8.13%45.19M30.40%200.7M
Credit Impairment Loss -6,106.33%-2.31M125.57%384.48K47.52%-796.4K135.39%1.4M-104.00%-37.25K-166.06%-1.5M-1,243.85%-1.52M2,354.80%593.98K-22.41%931.97K206.82%2.28M
Asset Impairment Loss 32.52%-178.86K-13.41%-2.63M58.65%-886.68K55.06%-440.52K55.58%-265.05K-21.96%-2.32M-116.27%-2.14M-245.39%-980.27K-412.35%-596.74K3.49%-1.9M
Other net revenue
Fair value change income -23.25%3.16M-27.13%14.57M-34.71%13.5M-44.65%7.98M-32.45%4.12M46.03%19.99M61.21%20.67M62.87%14.41M--6.09M--13.69M
Invest income 45.80%3.13M38.95%10.91M48.66%5.55M81.72%5.07M28.43%2.15M-72.31%7.85M-74.17%3.73M-78.12%2.79M-53.88%1.67M197.51%28.35M
-Including: Investment income associates -88.29%11.56K-72.51%144.33K--151.77K--132.52K--98.75K--524.98K----------------
Asset deal income ---2.29K-48.20%133.29K--13.74K--13.74K------257.29K----------------
Other revenue 80.25%19.67M-18.25%53.11M1.79%35.39M36.97%23.08M81.06%10.91M3.63%64.97M-41.28%34.77M0.78%16.85M-17.79%6.03M-7.04%62.69M
Operating profit 17.49%80.22M-7.25%241.74M0.23%211.44M-1.10%144.7M19.08%68.28M6.75%260.63M2.30%210.95M16.10%146.31M22.27%57.34M22.82%244.15M
Add:Non operating Income -89.17%269.18-93.18%104.22K-80.19%102.14K-18.28%12.56K-72.49%2.49K-81.45%1.53M521.55%515.46K-81.39%15.37K3,827.93%9.03K1,540.50%8.23M
Less:Non operating expense 218.70%129.97K20.81%201.55K-46.62%81.68K-66.49%51.26K4.85%40.78K-96.95%166.83K-97.11%153K102.07%152.95K56.90%38.89K2,119.23%5.46M
Total profit 17.37%80.09M-7.77%241.64M0.07%211.46M-1.03%144.66M19.07%68.24M6.10%261.99M5.13%211.31M15.98%146.17M22.27%57.31M24.05%246.92M
Less:Income tax cost -29.95%5.08M-2.60%15.07M12.20%17.75M13.89%13.14M106.87%7.25M6.73%15.47M5.95%15.82M32.80%11.54M-1.98%3.51M-30.62%14.49M
Add:Adjusted items effecting net profit -------------------------------0.01--------
Net profit 23.00%75.01M-8.09%226.57M-0.91%193.72M-2.31%131.52M13.35%60.99M6.06%246.52M5.06%195.49M14.74%134.64M24.28%53.8M30.46%232.43M
Net profit from continuing operation 23.00%75.01M-8.09%226.57M-0.91%193.72M-2.31%131.52M13.35%60.99M6.06%246.52M5.06%195.49M14.74%134.64M24.28%53.8M30.46%232.43M
Net profit of parent company owners 23.00%75.01M-8.09%226.57M-0.91%193.72M-2.31%131.52M13.35%60.99M6.06%246.52M5.06%195.49M14.74%134.64M24.28%53.8M30.46%232.43M
Earning per share
Basic earning per share 23.53%0.63-7.80%1.89-1.23%1.61-1.79%1.113.33%0.515.67%2.055.16%1.6314.29%1.1225.00%0.458.99%1.94
Diluted earning per share 23.53%0.63-7.80%1.89-1.23%1.61-1.79%1.113.33%0.515.67%2.055.16%1.6314.29%1.1225.00%0.458.99%1.94
Other composite income
Total composite income 23.00%75.01M-8.09%226.57M-0.91%193.72M-2.31%131.52M13.35%60.99M6.06%246.52M5.06%195.49M14.74%134.64M24.28%53.8M30.46%232.43M
Total composite income of parent company owners 23.00%75.01M-8.09%226.57M-0.91%193.72M-2.31%131.52M13.35%60.99M6.06%246.52M5.06%195.49M14.74%134.64M24.28%53.8M30.46%232.43M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion--------
Auditor --Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg